Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
13.40
-0.30 (-2.19%)
At close: May 5, 2026
DSE:IBP Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Cash & Equivalents | 1.77 | 4.34 | 10.4 | 11.3 | 28.69 | 35.59 |
Cash & Short-Term Investments | 1.77 | 4.34 | 10.4 | 11.3 | 28.69 | 35.59 |
Cash Growth | -85.13% | -58.22% | -8.04% | -60.60% | -19.38% | 157.17% |
Accounts Receivable | 232.95 | 196.24 | 202.26 | 223.65 | 218.93 | 245.75 |
Receivables | 232.95 | 196.24 | 202.26 | 223.65 | 218.93 | 245.75 |
Inventory | 94.68 | 103.57 | 161.59 | 178.61 | 181.09 | 202.09 |
Other Current Assets | 113.57 | 121.7 | 121.69 | 117.63 | 110.18 | 125.23 |
Total Current Assets | 442.97 | 425.85 | 495.94 | 531.2 | 538.89 | 608.67 |
Property, Plant & Equipment | 1,284 | 1,298 | 1,326 | 1,345 | 1,355 | 1,295 |
Other Intangible Assets | 0.44 | 0.48 | - | - | - | - |
Total Assets | 1,728 | 1,724 | 1,822 | 1,876 | 1,894 | 1,904 |
Accounts Payable | 16.7 | 17.41 | 0.86 | 0.83 | 0.93 | 0.62 |
Accrued Expenses | 12.32 | 12.48 | 10.32 | 12.8 | 13.16 | 20.98 |
Short-Term Debt | 19.47 | 20 | 24.2 | 43.61 | 75.36 | 84.94 |
Current Income Taxes Payable | 51.06 | 51.83 | 49.97 | 52.46 | 50.88 | 50.72 |
Other Current Liabilities | 15.93 | 15.87 | 14.81 | 15.1 | 13.88 | 13.11 |
Total Current Liabilities | 115.49 | 117.59 | 100.15 | 124.8 | 154.2 | 170.36 |
Long-Term Deferred Tax Liabilities | 153.54 | 150.24 | 141.1 | 129.14 | 114.56 | 108.18 |
Other Long-Term Liabilities | - | -0 | -0 | - | - | - |
Total Liabilities | 269.03 | 267.83 | 241.26 | 253.95 | 268.76 | 278.54 |
Common Stock | 1,162 | 1,162 | 1,162 | 1,162 | 1,162 | 1,137 |
Retained Earnings | 296.43 | 294.23 | 418.79 | 459.77 | 462.98 | 488.05 |
Comprehensive Income & Other | - | 0 | - | - | - | - |
Shareholders' Equity | 1,458 | 1,456 | 1,581 | 1,622 | 1,625 | 1,625 |
Total Liabilities & Equity | 1,728 | 1,724 | 1,822 | 1,876 | 1,894 | 1,904 |
Total Debt | 19.47 | 20 | 24.2 | 43.61 | 75.36 | 84.94 |
Net Cash (Debt) | -17.7 | -15.66 | -13.8 | -32.31 | -46.67 | -49.35 |
Net Cash Per Share | -0.15 | -0.13 | -0.12 | -0.28 | -0.40 | -0.43 |
Filing Date Shares Outstanding | 116.21 | 116.21 | 116.21 | 116.21 | 116.21 | 113.74 |
Total Common Shares Outstanding | 116.21 | 116.21 | 116.21 | 116.21 | 116.21 | 113.74 |
Working Capital | 327.48 | 308.26 | 395.79 | 406.39 | 384.69 | 438.3 |
Book Value Per Share | 12.55 | 12.53 | 13.60 | 13.96 | 13.98 | 14.29 |
Tangible Book Value | 1,458 | 1,456 | 1,581 | 1,622 | 1,625 | 1,625 |
Tangible Book Value Per Share | 12.55 | 12.53 | 13.60 | 13.96 | 13.98 | 14.29 |
Land | 160.11 | 160.11 | 160.11 | 160.11 | 162.11 | 93.5 |
Buildings | 236.17 | 236.17 | 236.17 | 236.17 | 236.17 | 232.92 |
Machinery | 1,061 | 1,061 | 1,061 | 1,061 | 1,037 | 967.42 |
Construction In Progress | 33.22 | 33.22 | 39.28 | 29.15 | 23.56 | 66.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.